BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18446731)

  • 1. To survive is not enough. Quality of life in CKD--the need for a new generation of health-oriented economists.
    De Santo NG; De Santo RM; Perna AF; Anastasio P; Bilancio G; Pollastro RM; Di Leo VA; Cirillo M
    J Nephrol; 2008; 21 Suppl 13():S32-50. PubMed ID: 18446731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to improve quality of life in patients with chronic kidney disease: a personal view.
    Berthoux F; Bartiromo M
    J Nephrol; 2008; 21 Suppl 13():S7-8. PubMed ID: 18446725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival is not enough.
    De Santo NG; Perna A; El Matri A; De Santo RM; Cirillo M
    J Ren Nutr; 2012 Jan; 22(1):211-9. PubMed ID: 22200445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do we need outcomes research in end stage renal disease?
    Nicolucci A; Procaccini DA
    J Nephrol; 2000; 13(6):401-4. PubMed ID: 11132755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflections on 'Survival is not enough--quality of life in CKD'.
    Mallamaci F
    J Nephrol; 2008; 21 Suppl 13():S163-4. PubMed ID: 18446752
    [No Abstract]   [Full Text] [Related]  

  • 6. The philosopher and the malady. A historical reckoning.
    Montano A
    J Nephrol; 2008; 21 Suppl 13():S12-7. PubMed ID: 18446727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in patients with end-stage renal disease treated with hemodialysis: survival is not enough!
    Kimmel PL; Cohen SD; Weisbord SD
    J Nephrol; 2008; 21 Suppl 13():S54-8. PubMed ID: 18446733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is psychonephrology?
    Levy NB
    J Nephrol; 2008; 21 Suppl 13():S51-3. PubMed ID: 18446732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider-patient relations and treatment choice in the era of fiscal incentives: the case of the end-stage renal disease program.
    Bovbjerg RR; Held PJ; Diamond LH
    Milbank Q; 1987; 65(2):177-202. PubMed ID: 3614141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life without quality. Reflections of a female focus group on life, health and kidney disease.
    Bandiziol P; Crosta A; De Martino F; Rizzo G; Ventrella M; Macaliuso E; Goria E; Milano M; Sanfilippo R; Mereu C; Piccoli GB
    J Nephrol; 2008; 21 Suppl 13():S124-8. PubMed ID: 18446745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ends of medicine: shaping new goals.
    Callahan D; Parens E
    Bull N Y Acad Med; 1995; 72(1):95-117. PubMed ID: 7581318
    [No Abstract]   [Full Text] [Related]  

  • 13. Towards cost-effective strategies for treatment of chronic kidney disease-mineral and bone disorder in Japan.
    Komaba H; Moriwaki K; Kamae I; Fukagawa M
    Ther Apher Dial; 2009 Oct; 13 Suppl 1():S28-35. PubMed ID: 19765256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life for children with chronic kidney disease.
    Goldstein SL; Gerson AC; Goldman CW; Furth S
    Semin Nephrol; 2006 Mar; 26(2):114-7. PubMed ID: 16530604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' priorities for health research: focus group study of patients with chronic kidney disease.
    Tong A; Sainsbury P; Carter SM; Hall B; Harris DC; Walker RG; Hawley CM; Chadban S; Craig JC
    Nephrol Dial Transplant; 2008 Oct; 23(10):3206-14. PubMed ID: 18445638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal dialysis is the best cost-effective alternative for maintaining dialysis treatment.
    Arrieta J; Rodríguez-Carmona A; Remón C; Pérez-Fontán M; Ortega F; Sánchez Tomero JA; Selgas R
    Nefrologia; 2011; 31(5):505-13. PubMed ID: 21959716
    [No Abstract]   [Full Text] [Related]  

  • 17. A qualitative study of patient's perceptions of a preventive renal programme in Colombia 2008.
    Yepes Delgado CE; Yepes Delgado FL; Vargas Betancourt ML; Orrego Orozco BE
    Chronic Illn; 2010 Dec; 6(4):252-62. PubMed ID: 20663800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we ameliorate quality of life in chronic kidney disease? The nephrologist's point of view.
    Ritz E
    J Nephrol; 2008; 21 Suppl 13():S9-11. PubMed ID: 18446726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-stage renal disease and chronic kidney disease in Brazil.
    Lugon JR
    Ethn Dis; 2009; 19(1 Suppl 1):S1-7-9. PubMed ID: 19484865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Financial incentives and dialysis].
    Keller F; Dress H; Mertz A; Marckmann G
    Med Klin (Munich); 2007 Aug; 102(8):659-64. PubMed ID: 17694285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.